Early Clopidogrel Versus Prasugrel Use Among Contemporary STEMI and NSTEMI Patients in the US: Insights From the National Cardiovascular Data Registry

BACKGROUND: P2Y12 antagonist therapy improves outcomes in acute myocardial infarction (MI) patients. Novel agents in this class are now available in the US. We studied the introduction of prasugrel into contemporary MI practice to understand the appropriateness of its use and assess for changes in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherwood, Matthew W., Wiviott, Stephen D., Peng, S. Andrew, Roe, Matthew T., DeLemos, James, Peterson, Eric D., Wang, Tracy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187510/
https://www.ncbi.nlm.nih.gov/pubmed/24732921
http://dx.doi.org/10.1161/JAHA.114.000849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187510/
https://www.ncbi.nlm.nih.gov/pubmed/24732921
http://dx.doi.org/10.1161/JAHA.114.000849

Ejemplares similares